To determine correlates of survival in primary pulmonary hypertension, we compared 41 echocardiography-Doppler and nine catheterization parameters with outcome in 26 patients. Mean follow-up was 19.7 months in survivors; mean survival was 4.8 months in 16 nonsurvivors. Cox life-table univariate analysis correlated two echocardiographic, three Doppler, and three catheterization variables with poor survival (pc0.05), and xj analysis ensured the best critical values: severity of pericardial effusion, heart rate of more than 87 beats/min, pulmonic flow acceleration time of less than 62 msec, tricuspid early flow deceleration (T-DEC) equal to or less than -300 cm2/sec, mitral early flow-to-atrial flow velocity ratio (M-E/A) equal to or less than 1.0, catheterization cardiac index (CI) equal to or less than 2.3 1/min/m2, mean pulmonary artery pressure of more than 61 mm Hg, and diastolic pulmonary artery pressure of more than 43 mm Hg. Multivariate life-table analysis of noninvasive variables revealed the severity of pericardial effusion to be independently significant (p=0.006), whereas analysis of catheterization variables revealed cardiac index to be independently significant (p =0.014). Combined multivariate analysis did not differ from the noninvasive results alone. Categorical modeling of the eight significant variables split at their critical values (present or absent) revealed M-E/A, T-DEC, and CI to be independently significant by multivariate analysis (p=0.0014). Analysis of the five echocardiography-Doppler variables alone revealed M-E/A, T-DEC, and heart rate to be independently significant (p=0.0016). In both cases, mortality increased with the number of critical values reached. Thus, both echocardiography-Doppler and catheterization parameters yield valuable information regarding outcome in primary pulmonary hypertension. Noninvasive methods alone may be used to evaluate prognosis without sacrifice when the diagnosis of primary pulmonary hypertension has been made and subsequent invasive testing is unavailable, too expensive, or too hazardous to perform. (Circulation 1989;80:353-360 
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We chose to use only planar cavity areas rather than calculating right and left ventricular and atrial volumes and ejection fractions, because such calculations would necessitate potentially erroneous geometric assumptions regarding chambers whose shapes are grossly distorted by the disease process under study. Further, even in normal subjects, the right atrium and ventricle may be quite irregular. [30] [31] [32] In addition, percent change in right ventricular area obtained from the apical four-chamber view has been closely correlated with nuclear and angiographic ejection fractions in patients with right heart pressure overload. 30 Pericardial effusions were evaluated in the parasternal long-and short-axis views and graded as absent, trace (systolic and diastolic separation of pericardial layers), small (separation less than 1 cm), or moderate (separation more than 1 but less than 2 cm) by an experienced observer (P.S.D.) blinded to patient outcome. Two-dimensional echocardiographic variables included heart rate, severity of pericardial effusion, systolic and diastolic areas, and percent change in area for each of the four cardiac chambers. Additional left ventricular variables included systolic and diastolic eccentricity indexes and systolic and diastolic short-axis endocardial areas. Doppler Echocardiography Two-dimensionally guided pulsed Doppler recordings were made with a commercially available ultrasonograph equipped with strip-chart recorder. Mitral and tricuspid inflows were recorded from the apical four-chamber view with the cursor positioned at the midpoint of each anulus, parallel to assumed flow. Pulmonic flow velocities were recorded from the parasternal short-axis view just above the level of the aortic valve with the cursor positioned in the midpoint of the pulmonic anulus. Three to six flow velocity profiles were digitized and averaged for each valve. Measurements included peak velocities of left and right ventricular inflow in early diastole and accompanying atrial systole, their ratios, the areas under the early and atrial velocity curves, and total flow velocity area. Mean rates of acceleration and deceleration of early diastolic flow were also determined. Pulmonic peak velocity, acceleration time (AT), and right ventricular systolic time intervals were measured at a paper speed of 50 mm/sec and included ejection time (ET), preejection period Figure 1) . Critical values are listed in Table 1 , and mean survival data for patients above and below critical values are listed in Table 2 . A weak relation was found with systolic eccentricity index (p =0.08); however, no significant relations were found between survival and chamber sizes or area shortening.
Cox life-table evaluation of Doppler tricuspid inflow and regurgitant velocities, mitral inflow velocities, pulmonic peak velocity, and right ventricular systolic time intervals revealed significant relations between poor survival and a lower ratio of mitral early-to-atrial flow in areas (M-E/A;p =0.02), shorter pulmonic acceleration time (AT;p=0.02), and slower tricuspid early flow deceleration (T-DEC; p=0.04) ( Table 1) . Critical values are listed in Table 1 , and mean survival data are listed in Table 2 . There were no significant relations found with other Doppler flow parameters, including peak velocity of tricuspid regurgitation (p=0.87). (Table 2 ). Multivariate analysis of echocardiographic variables alone revealed tricuspid early flow deceleration equal to or less than -300 cm2/sec, mitral E/A ratio equal to or less than 1.0, and heart rate of more than 87 beats/min to be independently significant (p=0.0016) (Figure 2 The decreased M-E/A ratio was secondary to both a decrease in early and an increase in atrial flow velocities as has been previously described. 42 Diastolic left ventricular dysfunction in PPH is thought to be the result of paradoxic septal motion, septal hypertrophy and noncompliance, or an eccentric, abnormal left ventricular configuration. 43 The correlation between T-DEC and survival supports the hypothesis that right as well as left ventricular diastolic dysfunction is present in severe PPH and is related to prognosis. Delayed mitral valve closure (E-F slope) and early flow deceleration have long been considered signs of diastolic dysfunction in the left ventricle. It is likely that pressure overload hypertrophy in the right as well as left ventricle should result in diastolic dysfunction with similar changes in the tricuspid flow patterns and that this would be associated with poor prognosis.
Because it is clinically useful to estimate a patient's prognosis, categoric grouping was performed. The results of a categoric echocardiographic and catheterization model combining three critical values (T-DEC. -300 cm2/sec, M-E/A<1.0, and CI'2.31 1/min/m2) best characterized outcome (Figure 2) , with both mean survival duration and percent mortality following a logical progression. The three variable noninvasive model (T-DEC, M-E/A, and heart rate) had similar significance (p<0.0014 vs. p<0.0016) and ability to characterize mortality risk. The value of echocardiography alone in assessing future outcome adds a welcome tool to the clinicians' armamentarium and suggests that after the diagnosis of primary pulmonary hypertension has been made, subsequent catheterization, with its added expense and morbidity, might be avoided in some cases.
It is important to note that while all patients did not receive identical therapy, our approach to therapy was uniform, with all receiving "optimal" treatment as defined by acute vasodilator trials and currently accepted medical practice.27 While similar treatment might appear to be desirable, it would have been unethical to either withhold treatment from vasodilator responders or to treat nonresponders given the attendant risks of drug therapy. Further, our data apply most closely to the expected clinical circumstance-one would most like to predict survival based on each patient receiving the best possible individualized treatment.
Although We have developed a model of echocardiographic and catheterization features associated with both increasing percent mortality and decreasing mean survival duration in patients with PPH. The present study does not address the value of serial comparisons of echocardiography-Doppler studies or the role of these studies in the consideration of heartlung transplantation. Future, prospective studies are needed to address these questions, determine the sensitivity and specificity of this model, and confirm the clinical use of our findings.
